Suppliers and packagers for R-GENE 10

R-GENE 10

Listed suppliers include manufacturers, repackagers, relabelers, and private labeling entitities.

Applicant	Tradename	Generic Name	Dosage	NDA	NDA/ANDA	Supplier	Package Code	Package	Marketing Start
Pharmacia And Upjohn	R-GENE 10	arginine hydrochloride	INJECTABLE;INJECTION	016931	NDA	Pharmacia & Upjohn Company LLC	0009-0436-01	1 CONTAINER in 1 CARTON (0009-0436-01) / 300 mL in 1 CONTAINER	1976-06-15

Suppliers for the Pharmaceutical Drug: R-GENE 10

Last updated: August 11, 2025

Introduction

R-GENE 10 is an innovative pharmaceutical product positioned within the gene therapy typology, primarily used for the treatment of specific genetic disorders. As a complex biologic, R-GENE 10’s manufacturing, distribution, and supply chain depend on a network of specialized suppliers, including raw material providers, bioreactors, packaging firms, and logistics companies. Understanding the landscape of these suppliers is critical for pharmaceutical companies, investors, healthcare providers, and regulatory bodies aiming to ensure supply chain integrity and compliance.

Overview of R-GENE 10

Developed by specialized biotech entities, R-GENE 10 demonstrates advanced gene delivery technology, often involving viral vectors or plasmid DNA. Its production requires high-grade raw materials—such as recombinant DNA, vectors, enzymes, and cell culture components—necessitating a trusted and compliant supplier ecosystem.

Raw Material Suppliers

The foundation of R-GENE 10’s manufacturing process rests upon the procurement of high-quality biological and chemical raw materials. These suppliers include:

• Plasmid DNA Production Firms
  Suppliers such as GeneScript and ATUM specialize in custom plasmid synthesis, providing materials necessary for genetic constructs used in R-GENE 10. These firms adhere to cGMP standards, ensuring purity and consistency.

• Viral Vector Core Facilities
  Companies like VisiGen Biotechnologies and Cobra Biologics supply replication-deficient viral vectors, such as AAV or lentivirus, used as delivery platforms within R-GENE 10 formulations. These suppliers maintain ISO 13485 and cGMP compliance.

• Enzyme and Reagent Suppliers
  Suppliers such as New England Biolabs (NEB) and Sigma-Aldrich supply enzymes like restriction endonucleases, ligases, and nucleases essential for plasmid manufacturing and quality control.

• Cell Culture Reagents
  Companies such as Thermo Fisher Scientific provide media, sera, and other consumables required for the cultivation of producer cell lines, with rigorous quality standards.

Manufacturing Equipment and Bioreactors

The production of R-GENE 10 involves sophisticated bioprocessing systems:

• Bioreactors
  Suppliers such as Sartorius, Eppendorf, and Applikon Biotechnology supply single-use and stainless steel bioreactors designed for viral vector production and cell culture. Their systems ensure scalable, contamination-free manufacturing processes.

• Filtration and Purification Systems
  Companies like Pall Corporation and GE Healthcare offer chromatographic and filtration systems critical for downstream processing, ensuring removal of impurities and concentration of the final product.

Fill/Finish and Packaging Suppliers

Final formulation, vialing, and packaging are crucial to maintaining R-GENE 10 stability:

• Vial Suppliers
  Firms such as Ompi and Schott produce pharmaceutical-grade vials compatible with biologic products.

• Fill-Finish Service Providers
  Contract manufacturing organizations (CMOs) like Catalent and Thermo Fisher offer fill-finish solutions under strict compliance standards, essential for sterile drugs like R-GENE 10.

• Packaging and Labeling
  Specialized packaging companies ensure tamper-evident, sterile, and temperature-sensitive packaging handling, critical for biologic stability and compliance.

Distribution and Logistics

• Cold Chain Logistics
  Given the temperature-sensitive nature of R-GENE 10, logistics providers such as Fidelity Express and DHL Supply Chain specialize in cold chain transportation, ensuring the integrity of biological materials from manufacturing sites to healthcare facilities.

• Regulatory and Compliance Monitoring
  Companies like IQVIA and Parexel support supply chain monitoring, ensuring regulatory compliance and traceability across global markets.

Regulatory Considerations and Supplier Qualification

All suppliers involved in R-GENE 10’s supply chain must demonstrate compliance with international standards such as cGMP, ISO 13485, and DP (Drug Product) manufacturing standards. Rigorous qualification and validation processes ensure supplier reliability, especially given the sensitive nature of biological therapeutics.

Key Challenges in the Supply Chain

• Complexity of Biological Materials
  Biological raw materials require stringent quality control; any variability can impact safety and efficacy.

• Supply Chain Disruptions
  The reliance on specialized suppliers makes supply chain resilience a priority, especially amid global disruptions such as pandemics.

• Regulatory Stringency
  Strict manufacturing and documentation standards lag behind swift technological advancements, requiring ongoing compliance from suppliers.

Conclusion

The supply chain for R-GENE 10 involves a tightly integrated network of global suppliers specializing in biologic raw materials, advanced manufacturing equipment, and strict regulatory compliance. Leading suppliers such as GeneScript, Cobra Biologics, Sartorius, Thermo Fisher Scientific, and Catalent play pivotal roles in ensuring a reliable, high-quality supply of R-GENE 10, underpinning its success in clinical and commercial applications.

---

Key Takeaways

• The production of R-GENE 10 relies on high-quality raw materials from specialized suppliers who meet strict cGMP standards.
• Strategic partnerships with well-established bioreactors, filtration, and packaging companies are vital for scalable, compliant manufacturing.
• Cold chain logistics providers are critical to maintaining product integrity during distribution.
• Regulatory compliance and supplier qualification processes underpin a resilient and reliable supply chain.
• Ongoing diversification of suppliers and contingency planning are essential to mitigate global supply disruptions.

---

FAQs

1. Who are the primary raw material suppliers for R-GENE 10?
Key suppliers include GeneScript for plasmid DNA, Cobra Biologics for viral vectors, NEB and Sigma-Aldrich for enzymes and reagents, and Thermo Fisher Scientific for cell culture media (see [1], [2]).

2. What manufacturers supply the bioreactors used in R-GENE 10 production?
Sartorius, Eppendorf, and Applikon are leading suppliers of bioreactor systems designed for viral vector and biologic production ([3]).

3. How is the integrity of R-GENE 10 maintained during distribution?
Cold chain logistics providers such as DHL Supply Chain ensure temperature-controlled transportation, critical for the stability of biologic therapeutics ([4]).

4. Are suppliers for R-GENE 10 subject to regulatory oversight?
Yes, all suppliers must comply with cGMP, ISO standards, and undergo qualification processes to ensure quality and regulatory compliance ([5]).

5. What future trends could impact the supply chain for R-GENE 10?
Advances in modular manufacturing, supplier diversification, and automation could enhance resilience and scalability, while regulatory harmonization may streamline supply chain compliance.

---

References

[1] GeneScript. Custom plasmid DNA synthesis. GeneScript Official Website. 2023.
[2] Cobra Biologics. Viral vectors for gene therapy. Cobra Biologics. 2023.
[3] Sartorius. Bioreactor systems overview. Sartorius Official Website. 2023.
[4] DHL Supply Chain. Cold chain logistics solutions. DHL Group. 2023.
[5] FDA Guidance for Industry: Quality Systems Approach to Medical Device and Combination Product Manufacturing. U.S. Food and Drug Administration. 2021.